Repligen
(NASDAQ:RGEN)
$168.04
0.99[0.59%]
At close: May 6
$168.04
0[0.00%]
After Hours: 4:07PM EDT
Q1 2024 Earnings were released on Wed May 1st, before the market open
The most recent conference call was at 8:30 AM, 5 days ago Click to view past webcast
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest

Repligen Stock (NASDAQ:RGEN), Quotes and News Summary

Repligen Stock (NASDAQ: RGEN) stock price, news, charts, stock research, profile.

Open$168.680
Close$168.040
Volume / Avg.448.408K / 494.475K
Day Range165.905 - 168.680
52 Wk Range110.450 - 211.130
Market Cap$9.389B
P/E Ratio618.704
Dividend Yield-
ExchangeNASDAQ
RSI
0
Short Interest
9.99%
Days to Cover13.2

Recent News

HealthStream Reports Upbeat Results, Joins Spotify, Ryder System And Other Big Stocks Moving Higher On Tuesday
Avi Kapoor
Aehr Test Systems Reports Preliminary Results, Joins Dyne Therapeutics, United Airlines And Other Big Stocks Moving Lower On Monday
U.S. stocks were lower, with the Dow Jones index falling around 100 points on Monday.
Avi Kapoor
What's Going On With Life Science-Focused Repligen Stock Today?
Repligen posts Q4 2023 results. CEO Tony Hunt highlights order strength in Filtration and Analytics. Positive momentum in new modalities; 2024 revenue forecast: $620-$650 million.
Vandana Singh
20%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
1
Dec 23
2
Feb
1
May
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
4.2
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
RGEN
MEDP

FAQ

Q

How do I buy Repligen (RGEN) stock?

A

You can purchase shares of Repligen (NASDAQ: RGEN) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Repligen's (RGEN) competitors?

A

Other companies in Repligen’s space includes: Medpace Hldgs (NASDAQ:MEDP), Agilent Technologies (NYSE:A), 10x Genomics (NASDAQ:TXG), Waters (NYSE:WAT) and Danaher (NYSE:DHR).

Q

What is the target price for Repligen (RGEN) stock?

A

The latest price target for Repligen (NASDAQ: RGEN) was reported by JP Morgan on Thursday, May 2, 2024. The analyst firm set a price target for 200.00 expecting RGEN to rise to within 12 months (a possible 19.02% upside). 17 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Repligen (RGEN)?

A

The stock price for Repligen (NASDAQ: RGEN) is $168.04 last updated Today at May 6, 2024 at 4:07 PM EDT.

Q

Does Repligen (RGEN) pay a dividend?

A

There are no upcoming dividends for Repligen.

Q

When is Repligen (NASDAQ:RGEN) reporting earnings?

A

Repligen’s Q2 earnings are confirmed for Wednesday, July 31, 2024.

Q

Is Repligen (RGEN) going to split?

A

There is no upcoming split for Repligen.

Q

What sector and industry does Repligen (RGEN) operate in?

A

Repligen is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.

People Also Watch